A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma
NCT07201064
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG:
SZ1003 injection
Sponsor
Guangdong ProCapZoom Biosciences Co., Ltd.